This reliance provides an opportunity for anti-estrogen medications such as tamoxifen to suppress their proliferation effectively by blocking the cancer cells’ estrogen receptors, thus reducing the hormone’s capacity to stimulate tumor expansion [64,65]. The gene discussed is ESR1; the disease is cancer.